is januvia a glp-1 vs Tradjenta: Compare Risks and Benefits All About The Januvia /
Description
In a systematic literature review of randomized controlled trials of GLP-1 based therapy in patients with obesity without T2DM, adverse events were reported in 8096 % of patients treated with liraglutide or semaglutide compared with 6396 % of placebo-treated patients
A lot of parts well done, at the right time
Lets explore what we do and dont yet know about weight loss medications and binge eating
Colhoun, H.M
J Clin Endocrinol Metab 2011;96(10):3067-3077
